Placenta cell therapy shows promise for tough transplant complication
Disease control
Terminated
This trial tested a treatment made from placenta cells (called decidua stroma cells) in 12 adults who had severe graft-versus-host disease (GVHD) after a stem cell transplant and did not respond to steroids. Patients received two doses of the cells or the best available standard …
Phase: PHASE2 • Sponsor: Mats Remberger • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC